Mineralys Therapeutics, Inc. MLYS Software and Technology Licenses, Net
Software and Technology Licenses, Net at other companies
Other financials
Where this comes from
Reported directly by Mineralys Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OtherAssetsNoncurrent.
The official record: Mineralys Therapeutics, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Mineralys Therapeutics, Inc.'s software and technology licenses, net.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Mineralys Therapeutics, Inc.'s software and technology licenses, net?
- Mineralys Therapeutics, Inc. (MLYS) reported software and technology licenses, net of $360K in Q1 2026.
- How has Mineralys Therapeutics, Inc.'s software and technology licenses, net changed year-over-year?
- Mineralys Therapeutics, Inc.'s software and technology licenses, net decreased by 9.3% year-over-year, from $397K to $360K.
- What is the long-term trend for Mineralys Therapeutics, Inc.'s software and technology licenses, net?
- Over 3 years (2022 to 2025), Mineralys Therapeutics, Inc.'s software and technology licenses, net has grown at a -38.4% compound annual growth rate (CAGR), from $1.63M to $382K.